Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

TMEM9 Activators

TMEM9 activators are a class of chemical compounds that specifically target and increase the activity of the transmembrane protein 9 (TMEM9). TMEM9 is a protein that resides within the cellular membrane and is believed to play a role in various cellular processes, including the regulation of ion channels and transporters, as well as the modulation of intracellular signaling pathways. The unique feature of activators in this class is their ability to interact with TMEM9, enhancing its natural function within the cell. These interactions may influence the protein's structural conformation, stability, or its interaction with other cellular components, thereby augmenting its activity. The chemical structures of TMEM9 activators can be diverse, ranging from small organic molecules to larger biomolecules, all designed or discovered based on their capacity to engage with TMEM9 in a way that promotes its functional role.

The exploration and identification of TMEM9 activators involve a combination of biochemical, genetic, and computational techniques to understand and manipulate the interaction between these compounds and the TMEM9 protein. High-throughput screening of chemical libraries can reveal potential activators, which are then subjected to further analysis to confirm and characterize their mode of action. Studies into the structure-activity relationship (SAR) of these compounds provide insights into which chemical moieties are essential for the activation of TMEM9. In addition to direct binding assays, techniques such as molecular docking and dynamic simulation are used to predict how these activators interact with TMEM9 at an atomic level. The elucidation of the three-dimensional structure of TMEM9 and its complex with activators is critical, as it allows for the refinement of activator design to achieve higher specificity and potency. Moreover, understanding the precise mechanism by which these activators enhance TMEM9 function requires detailed kinetic and biophysical studies, which can reveal the impact of activator binding on the protein's conformation and activity within the cellular membrane environment.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Bafilomycin A1

88899-55-2sc-201550
sc-201550A
sc-201550B
sc-201550C
100 µg
1 mg
5 mg
10 mg
$98.00
$255.00
$765.00
$1457.00
280
(6)

As an inhibitor of vacuolar-type H+-ATPase, it may upregulate TMEM9 expression to compensate for disrupted vesicle acidification.

Monensin A

17090-79-8sc-362032
sc-362032A
5 mg
25 mg
$155.00
$525.00
(1)

A sodium ionophore that disrupts lysosomal acidification, potentially increasing TMEM9 expression as a compensatory response.

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$172.00
$305.00
66
(3)

Induces ER stress, which could lead to an increase in TMEM9 expression due to the heightened need for vesicular trafficking.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

A known ER stressor that could enhance TMEM9 expression to manage increased demands on the secretory pathway.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Increases intracellular cAMP, which may enhance TMEM9 expression as part of the signaling pathways involved in vesicle dynamics.

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

Known to raise the pH of intracellular vesicles and might induce TMEM9 expression to restore normal vesicle acidification.

E-64

66701-25-5sc-201276
sc-201276A
sc-201276B
5 mg
25 mg
250 mg
$281.00
$947.00
$1574.00
14
(0)

Inhibits cysteine proteases and could lead to the upregulation of TMEM9 in response to altered proteolytic activity in vesicles.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

A proteasome inhibitor that may increase TMEM9 expression due to the accumulation of proteins requiring vesicular transport for degradation.

Concanamycin A

80890-47-7sc-202111
sc-202111A
sc-202111B
sc-202111C
50 µg
200 µg
1 mg
5 mg
$66.00
$167.00
$673.00
$2601.00
109
(2)

Another V-ATPase inhibitor that might induce TMEM9 expression to counteract impaired vesicular acidification.

Nigericin sodium salt

28643-80-3sc-201518A
sc-201518
sc-201518B
sc-201518C
sc-201518D
1 mg
5 mg
25 mg
1 g
5 g
$46.00
$112.00
$240.00
$7079.00
$27417.00
9
(2)

As an ionophore that alters membrane potential, it could influence TMEM9 expression to maintain vesicle function.